fibrinogen has been researched along with Androgen-Independent Prostatic Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YF; Man, YN | 1 |
1 other study(ies) available for fibrinogen and Androgen-Independent Prostatic Cancer
| Article | Year |
|---|---|
Systemic immune-inflammation index, serum albumin, and fibrinogen impact prognosis in castration-resistant prostate cancer patients treated with first-line docetaxel.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Docetaxel; Fibrinogen; Humans; Leukocyte Count; Lymphocytes; Male; Middle Aged; Neutrophils; Platelet Count; Prognosis; Prostatic Neoplasms, Castration-Resistant; Retrospective Studies; Risk Assessment; Serum Albumin; Survival Analysis | 2019 |